A Randomized, Open Label Study Comparing the Effect of CellCept Combined With 2 Regimens of Reduced Calcineurin Inhibitors on Kidney Function in Liver Transplant Patients.
Phase of Trial: Phase IV
Latest Information Update: 10 Nov 2014
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Calcineurin inhibitors
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Sponsors Roche
- 02 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jan 2012 Actual patient number changed from 82 to 88 as reported by ClinicalTrials.gov.
- 15 Mar 2011 Planned end date changed from 1 Aug 2011 to 1 Feb 2012 as reported by ClinicalTrials.gov.